Jie Zhang

EGFR Oncogenes Expressed In Glioblastoma Are Activated As Covalent Dimers And Paradoxically Stimulated By Erlotinib

A. Flohr, A. Mayweg, N. Ishiyama, 2019, bioRxiv.

Retraction Note to: Nucleolin Promotes TGF-β Signaling Initiation via TGF-β Receptor I in Glioblastoma

Chengjun Yao, Dongxiao Zhuang, Jie Zhang, 2017, Journal of Molecular Neuroscience.

RETRACTED ARTICLE: Nucleolin Promotes TGF-β Signaling Initiation via TGF-β Receptor I in Glioblastoma

Jie-shi Zhang, Chengjun Yao, Dongxiao Zhuang, 2014, Journal of Molecular Neuroscience.

Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

Winnie S. Liang, M. Berens, S. Byron, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas

M. Prados, C. James, S. Hariono, 2017, Journal of Neuro-Oncology.

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation

Susan M. Chang, M. Berger, M. McDermott, 2018, Cell reports.

RETRACTED ARTICLE: The association of Crk-like adapter protein with poor prognosis in glioma patients

Li Zhang, Chengjun Yao, Dongxiao Zhuang, 2014, Tumor Biology.

Acquired resistance to BRAF inhibition in BRAFV600E mutant gliomas

M. Prados, C. James, W. Weiss, 2016, Oncotarget.

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy

M. Prados, C. James, W. Weiss, 2015, Oncotarget.

RETRACTED ARTICLE: Nucleolin Promotes TGF-β Signaling Initiation via TGF-β Receptor I in Glioblastoma

Chengjun Yao, Dongxiao Zhuang, Jie Zhang, 2014, Journal of Molecular Neuroscience.

EGFR blockade prevents glioma escape from BRAFV600E targeted therapy.

M. Prados, C. James, W. Weiss, 2015, Oncotarget.